Publications by authors named "Theresia M Westers"

Claim this Profile
T
Toward immunoprofiling in MDS: A computational study of the bone marrow immune microenvironment.
Margot F van Spronsen, Luca L G Janssen, Tessa Poolman, Theresia M Westers, Yvan Saeys

Cytometry B Clin Cytom· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inflammatory T-cell-stromal axis contributes to hematopoietic stem/progenitor cell failure and clonal evolution in human myelodysplastic syndrome.
Lanpeng Chen, Yujie Bian, Eline Pronk, Claire van Dijk, Tim V D van Tienhoven, Theresia M Westers

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients.
Florentien E M In't Hout, Thessa N Scheele, Theresia M Westers, Canan Alhan, Carolien Duetz

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the diagnostic potential of 17 immunophenotypic core markers defined by the in an independent cohort of patients with MDS.
Coen R Veenstra, Canan Alhan, Theresia M Westers, Arjan A van de Loosdrecht

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cells.
Tom Reuvekamp, Luca L G Janssen, Lok Lam Ngai, Jannemieke Carbaat-Ham, Daphne den Hartog, Theresia M Westers

Cytometry B Clin Cytom· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine.
Francesca Tiso, Florentien E M In 't Hout, Ruth Knops, Leonie I Kroeze, Arno van Rooij, Theresia M Westers

Hemasphere· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms.
Luca L G Janssen, Nathalie van Leeuwen-Kerkhoff, Theresia M Westers, Tanja D de Gruijl, Arjan A van de Loosdrecht

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells.
Margot F van Spronsen, Sofie Van Gassen, Carolien Duetz, Theresia M Westers, Yvan Saeys

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Cristina A Tentori, Lin P Zhao, Benedetta Tinterri, Kathryn E Strange, Katharina Zoldan, Theresia M Westers

Hemasphere· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001.
Luca L G Janssen, Theresia M Westers, Jeroen Rovers, Peter J M Valk, Jacqueline Cloos

Hemasphere· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging the status flow: how artificial intelligence is advancing diagnosis of myelodysplastic neoplasms.
Carolien Duetz, Theresia M Westers, Arjan A Van de Loosdrecht

Haematologica· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysplasia and PNH-type cells in bone marrow aspirates of myelodysplastic syndromes.
Theresia M Westers, Canan Alhan, Heleen A Visser-Wisselaar, Dana A Chitu, Arjan A van de Loosdrecht

Cytometry B Clin Cytom· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The flow cytometry myeloid progenitor count: A reproducible parameter for diagnosis and prognosis of myelodysplastic syndromes.
Ulrika Johansson, Neil McIver-Brown, Matthew Cullen, Carolien Duetz, Alan Dunlop, Theresia M Westers

Cytometry B Clin Cytom· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry.
Costa Bachas, Carolien Duetz, Margot F van Spronsen, Jan Verhoeff, Juan J Garcia Vallejo, Theresia M Westers

Cytometry B Clin Cytom· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of developmental and cell type-specific expression of glycoconjugates on hematopoietic cells: a new characteristic of myelodysplastic neoplasms (MDS).
Margot F van Spronsen, Sophie Horrevorts, Claudia Cali, Theresia M Westers, Sofie Van Gassen

Leukemia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression.
Margot F van Spronsen, Diana Hanekamp, Theresia M Westers, Noortje van Gils, Eline Vermue

Leukemia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.
Vincent H J van der Velden, Frank Preijers, Ulrika Johansson, Theresia M Westers, Alan Dunlop

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
Arjan A van de Loosdrecht, Wolfgang Kern, Anna Porwit, Peter Valent, Sharham Kordasti, Theresia M Westers

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry.
Orianne Wagner-Ballon, Peter Bettelheim, Jeroen Lauf, Frauke Bellos, Matteo Della Porta, Theresia M Westers

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A series of case studies illustrating the role of flow cytometry in the diagnostic work-up of myelodysplastic syndromes.
Theresia M Westers, Leonie Saft, Vincent H J van der Velden, Jeroen G Te Marvelde, Alan Dunlop

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.
Wolfgang Kern, Theresia M Westers, Frauke Bellos, Marie Christine Bene, Peter Bettelheim

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Anna Porwit, Marie C Béné, Carolien Duetz, Sergio Matarraz, Uta Oelschlaegel, Theresia M Westers

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes.
Nathalie Van Leeuwen-Kerkhoff, Theresia M Westers, Pino J Poddighe, Giovanni A M Povoleri, Jessica A Timms

Haematologica· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational flow cytometry as a diagnostic tool in suspected-myelodysplastic syndromes.
Carolien Duetz, Sofie Van Gassen, Theresia M Westers, Margot F van Spronsen, Costa Bachas

Cytometry A· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype.
Carolien Duetz, Theresia M Westers, Florentien E M In 't Hout, Eline M P Cremers, Canan Alhan

Br J Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis